Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

With the rising popularity of telehealth providers offering GLP-1 medications ... or liquid drops, typically in a daily ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as ...

With promising Phase 1 results in hand, Metsera hopes to develop a longer-lasting GLP-1 injection along with other types of ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

The correlation between the rise of these appetite-suppressing drugs and the decline in snack sales suggests that as more ...

In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a ...

We're living in a world full of foods that trigger constant hunger, cravings and thoughts about eating. Is it even possible ...

The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...